The IO360° Annual Meeting is a premier event focused on the rapidly evolving field of immuno-oncology (IO). The meeting features a comprehensive program with in-depth presentations, panel discussions, and interactive sessions on the most cutting-edge topics in immuno-oncology, including emerging therapies, clinical trials, regulatory updates, and new scientific discoveries. Attendees have the chance to explore the future of cancer treatments, share insights, and engage in collaborative discussions that aim to accelerate the development of novel therapies.

Additionally, the IO360° Annual Meeting serves as a hub for networking, offering valuable opportunities to connect with key stakeholders, foster partnerships, and drive business development in the IO space. This event is essential for anyone looking to stay at the forefront of immuno-oncology research and innovations.

Our team is attending to share how researchers are using our novel imaging agent, CD8 ImmunoPET. Schedule a time to meet with one of our experts.

ImaginAb staff attending the event

Matthew Hoover

Director, Business Development

Calmen Tihansky

Manager, Business Development

Meeting Request

back to News and Events